Business
AI summarySwedish Orphan Biovitrum AB is a biopharma company that provides medicines in haematology, immunology, and specialty care across Europe, North America, the Middle East, Asia, and Australia, organized into Haematology, Immunology, and Specialty Care segments. Its products include haemophilia treatments such as Alprolix, ALTUVOCT, Elocta/Eloctate, and Kineret, along with Aspaveli/Empaveli, Doptelet, Gamifant, Orfadin, Synagis, VONJO, and Zynlonta, and it develops drug substances for Pfizer while collaborating with partners including Sanofi, Apellis, ADC Therapeutics, and Cartesian Therapeutics. The company was incorporated in 1939 and is headquartered in Stockholm.
